In the cancer type multiple myeloma, the malignant cells differ significantly from normal cells regarding the layer of ...

Scientists have discovered that rheumatoid arthritis (RA) doesn't start when the pain begins. It silently starts years earlier. RA is a debilitating autoimmune disease that causes painful joint ...

Aditxt’s Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at ...

While adding in new drugs—rapamycin has shown to lengthen the life of animals as much as 15 percent—has an impact, achieving the wild life spans of 1,000 to 20,000 years would require cells that don’t ...

British scientist says humans could live 20,000 years through DNA reprogramming and cellular repair technology that ...

In the human body, stem cells process genetic information in an exceptionally reliable and very fast manner.  To do this, they specifically access certain sections of the DNA in the cell nucleus.

Scientists show how stem cells process DNA with speed and precision, revealing principles that could lead to programmable DNA-based chips for biotechnology and medicine.

Anti-aging biotech NewLimit plans to push a liver-rejuvenating mRNA medicine into the clinic with the aid of a $130 million series B fundraising round. The round was led by Kleiner Perkins alongside ...

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”, or the “Company”), a social innovation platform accelerating promising health innovations, today announced an update on its wholly owned subsidiary Adimune, Inc.